GSK extends Nicorette line
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline launches Nicorette Mini Lozenges in discreet, pocket-size vials to help smokers address cravings and withdrawal symptoms as they try to quit. The firm said April 27 the line extension dissolves up to three times faster than other nicotine replacement lozenges "and can double a smoker's chances of successfully quitting versus placebo." GSK also announced a "Mini Moments" contest on Facebook allowing consumers to share reasons for quitting. The mint lozenges come in 2-mg and 4-mg sizes. A package of 81 retails for a suggested $55.49